Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus
A scientific statement from the American Heart Association and the American Diabetes Association
- John B. Buse, MD, PHD, CO-CHAIR1,
- Henry N. Ginsberg, MD, CO-CHAIR2,
- George L. Bakris, MD3,
- Nathaniel G. Clark, MD, MS, RD4,
- Fernando Costa, MD5,
- Robert Eckel, MD6,
- Vivian Fonseca, MD7,
- Hertzel C. Gerstein, MD, MSC, FRCPC8,
- Scott Grundy, MD, PHD9,
- Richard W. Nesto, MD10,
- Michael P. Pignone, MD, MPH11,
- Jorge Plutzky, MD12,
- Daniel Porte, MD13,
- Rita Redberg, MD14,
- Kimberly F. Stitzel, MS, RD5 and
- Neil J. Stone, MD15
- 1University of North Carolina School of Medicine, Chapel Hill, North Carolina
- 2Department of Medicine, Columbia University, New York, New York
- 3Rush Presbyterian/St. Luke’s Medical Center, Chicago, Illinois
- 4American Diabetes Association, Alexandria, Virginia
- 5American Heart Association, Dallas, Texas
- 6University of Colorado Health Sciences Center, Denver, Colorado
- 7Tulane University Health Sciences Center, New Orleans, Louisiana
- 8McMaster University Medical Center, Hamilton, Ontario, Canada
- 9Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas, Texas
- 10Lahey Clinic Medical Center, Burlington, Massachusetts
- 11Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
- 12Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
- 13VA San Diego Health Care, San Diego, California
- 14Division of Cardiology, University of California, San Francisco, San Francisco, California
- 15Feinberg School of Medicine, Northwestern University, Chicago, Illinois
- Address correspondence to Henry N. Ginsberg, MD, College of Physicians and Surgeons, Irving Center for Clinical Research, 630 W. 168th St., P&F 9-510, New York, NY 10032. E-mail: hng1{at}columbia.edu
Abstract
The American Heart Association (AHA) and the American Diabetes Association (ADA) have each published guidelines for cardiovascular disease prevention: the ADA has issued separate recommendations for each of the cardiovascular risk factors in patients with diabetes, and the AHA has shaped primary and secondary guidelines that extend to patients with diabetes. This statement will attempt to harmonize the recommendations of both organizations where possible but will recognize areas in which AHA and ADA recommendations differ.
- ACCORD, Action to Control Cardiovascular Risk in Diabetes
- ADA, American Diabetes Association
- AHA, American Heart Association
- ARB, angiotensin receptor blocker
- CHD, coronary heart disease
- CVD, cardiovascular disease
- FIELD, Fenofibrate Intervention and Event Lowering in Diabetes
- NHLBI, National Heart, Lung, and Blood Institute
Footnotes
-
This statement was approved by the American Heart Association Science Advisory and Coordinating Committee on 29 August 2006 and by the American Diabetes Association Professional Practice Committee on 12 September 2006.
Disclosure of potential duality of interest for each author can be found in the APPENDIX on p. 169.
Simultaneous publication: This statement is being published simultaneously in Circulation and Diabetes Care by the American Heart Association and the American Diabetes Association.
© 2006 by the American Diabetes Association, Inc., and the American Heart Association, Inc. Copying with attribution allowed for any noncommercial use of the work.
- DIABETES CARE
